Panasonic Connect Europe Talks Shop At The Retail Technology Show 2023
A range of edge technologies and AI-powered solutions for retail and the supply chain will…
Year: 2023
Better Choice and Pet Supermarket Announce Partnership
Pet Supermarket will Offer Halo Brand in 75 Retail Stores in the USA Halo Products…
Assertio Appoints Dr. Howard Franklin as Senior Vice President, Medical
LAKE FOREST, Ill., March 06, 2023 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
AIM ImmunoTech Issues Letter to Stockholders
Year marked by noteworthy operational execution and clinical development progress across pipeline Company reiterates commitment…
Longeveron to Announce Fourth Quarter and Full Year Financial Results on March 10, 2023
Live conference call on Friday, March 10 at 8:30 a.m. ET MIAMI, March 06, 2023…
Bellerophon Therapeutics Announces $5 Million Registered Direct Offering
WARREN, N.J., March 06, 2023 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or…
Anti-Properdin Antibody (NM3086) Demonstrates Efficacy in a Primate Model of Wet-AMD and Dry-AMD
Figure 1 Fluoresceine angiogram data from three animals treated with NM3086 (bottom) and three that…
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on Monday, March 13, 2023
CAMBRIDGE, Mass., March 06, 2023 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage…
Nexcella to Discuss Recent Positive NXC-201 Clinical Data In AL Amyloidosis and Multiple Myeloma at the 35th Annual Roth Conference on March 14
LOS ANGELES, March 06, 2023 (GLOBE NEWSWIRE) — Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”),…
Windtree Finds Cardiogenic Shock Has High Cost of US Patient Care and Plans Innovation with the Unique Profile of Istaroxime
US Hospital Claims Data Reveals Cardiogenic Shock Patients Have an Average Hospital Length of Stay…
BioVie Announces Additional Findings from Phase 2 Parkinson’s Disease Trial: More patients treated with NE3107 experienced morning “on state” with levodopa withheld overnight compared to those treated with placebo
6 out of 20 patients treated with NE3107 experienced a morning “on state” while 0…
Medexus to Participate in 35th Annual Roth Conference
TORONTO and CHICAGO, March 06, 2023 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased…
FDA Approves UDENYCA® Autoinjector
– UDENYCA® is the only pegfilgrastim therapy delivered in a convenient, easy-to-administer prefilled autoinjector to…
ImmixBio to Discuss Recent Positive NXC-201 Clinical Data in AL Amyloidosis and Multiple Myeloma at the 35th Annual Roth Conference on March 14
LOS ANGELES, March 06, 2023 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”,…
Ikena Oncology Receives FDA Fast Track Designation for Novel AHR Antagonist IK-175 in Combination with Nivolumab to Treat Urothelial Carcinoma
BOSTON, March 06, 2023 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted…
Amarin Highlights New Evidence of Therapeutic Value of EPA in Reducing Cardiovascular Events in At-Risk Patients Presented at ACC.23/WCC
–In Vitro Data Presentations Support Antithrombotic and Antioxidant Effects of EPA Compared with DHA, No…
SciSparc Successfully Completed Production of its Proprietary Drug Candidate SCI-110 for its Upcoming Clinical Trial On Tourette Syndrome
TEL AVIV, Israel, March 06, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company”…
Sensei Biotherapeutics to Participate in Oppenheimer’s 33rd Annual Healthcare Conference
BOSTON, March 06, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results
New Drug Application for VP-102 assigned PDUFA goal date of July 23, 2023 VP-102 has…
Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR
Relay Therapeutics to host conference call following AACR presentation CAMBRIDGE, Mass., March 06, 2023 (GLOBE…